Discussion on applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis [5]

Pancreas

Volumn 33, Issue 1, 2006, Pages 106-107

  Radenkovic, Dejan V ^a   Bajec, Djordje D ^a   Karamarkovic, Aleksandar R ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; D DIMER; PROTEIN C;

ACUTE PANCREATITIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; EARLY DIAGNOSIS; FATALITY; HEMOSTASIS; HUMAN; LETTER; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PARAMETER; PRIORITY JOURNAL; SURVIVAL;

EID: 33745727201     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000226887.78698.2d     Document Type: Letter

References (9)

1. Maeda K, Hirota M, Ichihara A, et al. Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas. 2006;32:87-92.
2. Shinowara GY, Stutman LJ, Walters MI, et al. Hypercoagulability in acute pancreatitis. Am J Surg. 1963;105:714-719.
3. Radenkovic D, Bajec D, Karamarkovic A, et al. Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. Pancreas. 2004;29:152-156.
4. Salomone T, Tosi P, Palareti G, et al. Coagulative disorders in human acute pancreatitis: role of D-dimer. Pancreas. 2003;26:111-116.
5. Ottesen LH, Bladbjerg EM, Osman M, et al. Protein C activation during the initial phase of experimental acute pancreatitis in the rabbit. Dig Surg. 1999;16:486-495.
6. Mentula P, Lindstrom O, Kylanpaa L, et al. Up-regulated but insufficient generation of activated protein C is associated with development of multi-organ failure in severe acute pancreatitis. Pancreas. 2005;31:456.
7. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344: 699-709.
8. Machala W, Wachowicz N, Komorowska A, et al. The use of drotrecogin alfa (activated) in severe sepsis during acute pancreatitis - two case studies. Med Sci Monit. 2004;10:CS31-CS36.
9. Yamanel L, Mas MR, Comert B, et al. The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care. 2005;9:R184-R190.